M. ÖZKAN, "The prognostic significance of increased MCV during capecitabine treatment in breast cancer," 1. Nema Congress , İstanbul, Turkey, 2013
ÖZKAN, M. 2013. The prognostic significance of increased MCV during capecitabine treatment in breast cancer. 1. Nema Congress , (İstanbul, Turkey).
ÖZKAN, M., (2013). The prognostic significance of increased MCV during capecitabine treatment in breast cancer . 1. Nema Congress, İstanbul, Turkey
ÖZKAN, METİN. "The prognostic significance of increased MCV during capecitabine treatment in breast cancer," 1. Nema Congress, İstanbul, Turkey, 2013
ÖZKAN, METİN. "The prognostic significance of increased MCV during capecitabine treatment in breast cancer." 1. Nema Congress , İstanbul, Turkey, 2013
ÖZKAN, M. (2013) . "The prognostic significance of increased MCV during capecitabine treatment in breast cancer." 1. Nema Congress , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={METİN ÖZKAN}, title={The prognostic significance of increased MCV during capecitabine treatment in breast cancer}, congress name={1. Nema Congress}, city={İstanbul}, country={Turkey}, year={2013}}